Cytori to Webcast at the JMP Securities Healthcare Conference on July 10, 2013

Updated

Cytori to Webcast at the JMP Securities Healthcare Conference on July 10, 2013

SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics, Inc. (NAS: CYTX) will present and provide a webcast of their corporate presentation at JMP Securities Healthcare Conference at 12:30 PM (ET) on Wednesday, July 10, 2013 in New York.

The webcast may be accessed under "Webcasts" in the Investor Relations section of the Company's website. The webcast can be accessed live and will be available for replay after the presentation on the Company's website.


About Cytori

Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution® system product family. www.cytori.com



Cytori Therapeutics, Inc.
Megan McCormick
+1.858.875.5279
mmccormick@cytori.com

KEYWORDS: United States North America California New York

INDUSTRY KEYWORDS:

The article Cytori to Webcast at the JMP Securities Healthcare Conference on July 10, 2013 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement